TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
IBIO

iBio, Inc.

Healthcare · Biotechnology

0.7317$ -4.0% vs. previous close Closing price · As of: Nov 13, 2026

Statements

Balance Sheet

iBio, Inc. (IBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 89 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IBIO
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26
34 50 29 25 22 19 23 64 64 86 99 89
20 36 16 12 8.3 6.1 9.7 51 53 77 92 81
2.8 5.3 14 11 7.0 5.0 8.6 28 29 48 56 45
2.8 5.3 14 11 7.0 5.0 8.6 50 53 75 88 77
1.8 14 0.7 – 0.0 – 0.1 0.1 0.0 0.0 1.1 1.2
14 – – – – – – – – – – –
5.4 5.4 5.4 5.4 6.1 6.1 6.8 6.8 4.3 1.8 1.8 2.6
25 25 7.4 6.8 7.8 7.7 8.3 8.1 7.8 8.3 13 10
22 21 3.8 3.5 4.7 5.4 6.1 6.0 5.9 6.5 12 8.6
14 14 1.0 1.0 0.9 1.4 1.3 1.2 0.5 0.5 0.5 0.6
1.9 1.2 0.4 0.9 0.6 1.5 2.2 2.8 2.7 3.0 4.4 4.4
– 0.8 0.8 0.7 0.6 – – – – – – –
9.2 25 21 18 14 11 15 56 57 78 86 79
-303 -306 -314 -318 -322 -327 -332 -338 -347 -355 -365 -373
1.9 3.7 8.6 8.6 9.1 9.9 16 53 99 120 145 152

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?